duration of neutropenia 30 days [clinicaltrials_resource:adc07672a334c4e39d6cf7b8664051e1]

duration of neutropenia 30 days [clinicaltrials_resource:adc07672a334c4e39d6cf7b8664051e1]

number of days absolute neutrophil count less than 500 during the nadir period after administration of high dose chemotherapy
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:adc07672a334c4e39d6cf7b8664051e1
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors [clinicaltrials:NCT00003269]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

duration of neutropenia 30 days [clinicaltrials_resource:adc07672a334c4e39d6cf7b8664051e1]

number of days absolute neutrophil count less than 500 during the nadir period after administration of high dose chemotherapy
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:adc07672a334c4e39d6cf7b8664051e1
Bio2RDF identifier
adc07672a334c4e39d6cf7b8664051e1
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:adc07672a334c4e39d6cf7b8664051e1
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
description
number of days absolute neutro ...... tion of high dose chemotherapy
identifier
clinicaltrials_resource:adc07672a334c4e39d6cf7b8664051e1
title
duration of neutropenia 30 days
@en
inDataset
type
label
duration of neutropenia 30 day ...... 07672a334c4e39d6cf7b8664051e1]
@en